Milestone Scientific Forms Global Advisory Board In Advance Of The Finalization Of The 400 Patient Clinical Study

LIVINGSTON, NJ--(Marketwired - February 18, 2016) - Milestone Scientific Inc. (NYSE MKT: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced it has formed a Global Advisory Board to aid in the commercialization of its medical instruments and also appointed industry veteran Bob Miglani as its inaugural member.

Bob Miglani has been with Pfizer Inc. for 23 years, where he held various senior sales, pricing, reimbursement, corporate affairs, as well as market access roles, and was responsible for managing projects and strategies in multiple countries including the U.S., Europe and India. His most recent role has been as Senior Director, External Medical Affairs at Pfizer Inc., where he has been developing innovative partnerships with medical and healthcare organizations in the U.S and around the world in the area of health and wellness innovation, new customer partnerships and public health. In 2014, he was awarded the Top 50 Asian Americans in Business Award.

Leonard Osser, CEO of Milestone Scientific commented: "The establishment of our Global Advisory Board will be an important resource as we move toward the worldwide rollout of our epidural instrument. We are delighted to welcome Bob as the first member of our new Global Advisory Board. He brings extensive business-to-business and consumer experience to help us realize the full potential of our instruments. The appointment comes at a key inflection point as we are now entering the final stage of U.S. clinical trials of our epidural instrument and we are close to reaching our enrollment goal of up to 400 patients. Based on the interim analysis of the clinical study that achieved the goal set by the FDA IDE Investigational Plan, we expect the final clinical trial data and accompanying statistical analysis to be completed in the next few weeks. We anticipate that the additional validation from U.S clinical trials and FDA approval will also accelerate the commercial launch of our epidural instrument in Europe and around the world."

About Milestone Scientific Inc.

Milestone Scientific Inc. (MLSS) is a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies. Milestone's computer-controlled systems make injections precise, efficient, and virtually painless. For more information please visit our website:

Back to news